FGFR1 extracellular domain combination therapies for lung cancer
作者： Li Long , Thomas Brennan
DOI:
关键词:
摘要: Methods of treating cancer comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule in combination with at least one additional therapeutic agent selected from docetaxel, paclitaxel, vincristine, carboplatin, cisplatin, oxaliplatin, doxorubicin, 5-fluorouracil (5-FU), leucovorin, pemetrexed, and bevacizumab are provided. Dosage packs also In some embodiments, dosage pack comprises instructions for agent.
lens.org 参考文章(163)
Fernando Carceller, Sylvie Lemière, Pedro Cuevas, James P. Di Santo, Demirkan B. Gürsel, Andreas Bikfalvi, Patrick Auguste, Diana Reimers, Inhibition of Fibroblast Growth Factor/Fibroblast Growth Factor Receptor Activity in Glioma Cells Impedes Tumor Growth by Both Angiogenesis-dependent and -independent Mechanisms Cancer Research. ,vol. 61, pp. 1717- 1726 ,(2001)
Mathis Grossmann, Mariusz W. Szkudlinski, Joseph E. Tropea, Leonora A. Bishop, N. Rao Thotakura, Peter R. Schofield, Bruce D. Weintraub, Expression of Human Thyrotropin in Cell Lines with Different Glycosylation Patterns Combined with Mutagenesis of Specific Glycosylation Sites CHARACTERIZATION OF A NOVEL ROLE FOR THE OLIGOSACCHARIDES IN THE IN VITRO AND IN VIVO BIOACTIVITY Journal of Biological Chemistry. ,vol. 270, pp. 29378- 29385 ,(1995) , 10.1074/JBC.270.49.29378
Ernestine Lee, Thomas Linnemann, Robert Forgan Halenbeck, Elizabeth Bosch, Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof ,(2006)
Amelia Compagni, Maria-Antonietta Impagnatiello, Matt Cotten, Petra Wilgenbus, Gerhard Christofori, Fibroblast Growth Factors Are Required for Efficient Tumor Angiogenesis Cancer Research. ,vol. 60, pp. 7163- 7169 ,(2000)
Harold Keer, Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins ,(2011)
Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac, Treating cancer with viral nucleic acid ,(2008)
D E Johnson, J Lu, H Chen, S Werner, L T Williams, The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Molecular and Cellular Biology. ,vol. 11, pp. 4627- 4634 ,(1991) , 10.1128/MCB.11.9.4627
Pei Jin, Michael H. Shepard, Cell surface receptor isoforms and methods of identifying and using the same ,(2005)
T D Bjornsson, G Levy, Pharmacokinetics of heparin. II. Studies of time dependence in rats. Journal of Pharmacology and Experimental Therapeutics. ,vol. 210, pp. 243- 246 ,(1979)
Lorianne Masuoka, Changjiang Zeng, Ernestine Lee, Kristen Pierce, Kevin Hestir, Elizabeth Bosch, Justin G. P. Wong, Yan Wang, Keting Chu, Lewis T. Williams, Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention ,(2004)